Paul's career spans 40 years, building and growing global sales, marketing and service operations in computational chemistry and discovery informatics companies. His background encompasses leadership roles at Oxford Molecular and Accelrys (now Biovia), Oxford Drug Discovery and at the Cambridge Crystallographic Data Centre. He was founder & CEO at the machine learning based IT security company Secerno (acquired by Oracle). He spent several years as Executive Vice President, Sales, at Schrödinger, a leader in computational chemistry, where he built business operations around the world.

Paul is currently Chief Business Officer at X-Chem, the pioneer in DNA-encoded library screening. He holds a chemistry degree from Oxford University and an MBA.